MAPT and Alzheimer disease: AD is a progressive neurodegenerative disorder, characterized by two major pathological hallmarks: amyloid-beta (Aβ) deposition within senile plaques (extracellular) and the accumulation of hyperphosphorylated and truncated tau protein (intracellular) [61].